These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 38406797)
1. An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction. Sathipati SY; Tsai MJ; Aimalla N; Moat L; Shukla SK; Allaire P; Hebbring S; Beheshti A; Sharma R; Ho SY NAR Genom Bioinform; 2024 Mar; 6(1):lqae022. PubMed ID: 38406797 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma. Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666 [TBL] [Abstract][Full Text] [Related]
3. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis. Zheng L; Wang J; Jiang H; Dong H Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342 [TBL] [Abstract][Full Text] [Related]
4. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues. Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314 [TBL] [Abstract][Full Text] [Related]
5. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM Front Oncol; 2020; 10():756. PubMed ID: 32509578 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children. Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219 [TBL] [Abstract][Full Text] [Related]
8. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes. Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496 [TBL] [Abstract][Full Text] [Related]
10. Identification of Three Circulating MicroRNAs in Plasma as Clinical Biomarkers for Breast Cancer Detection. Wang S; Li L; Yang M; Wang X; Zhang H; Wu N; Jia K; Wang J; Li M; Wei L; Liu J J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615122 [TBL] [Abstract][Full Text] [Related]
11. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test. Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801 [TBL] [Abstract][Full Text] [Related]
12. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases. Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475 [TBL] [Abstract][Full Text] [Related]
13. Identification of miRNAs in extracellular vesicles as potential diagnostic markers for pediatric epilepsy and drug-resistant epilepsy via bioinformatics analysis. Ruan Y; Deng X; Liu J; Xiao X; Yang Z Front Pediatr; 2023; 11():1199780. PubMed ID: 37469680 [TBL] [Abstract][Full Text] [Related]
14. Survival associated miRNA signature in patients with head and neck carcinomas. Yerukala Sathipati S; Ho SY Heliyon; 2023 Jun; 9(6):e17218. PubMed ID: 37360084 [TBL] [Abstract][Full Text] [Related]
15. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers. Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427 [TBL] [Abstract][Full Text] [Related]
16. Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis. Liu M; Mo F; Song X; He Y; Yuan Y; Yan J; Yang Y; Huang J; Zhang S PeerJ; 2021; 9():e12147. PubMed ID: 34616615 [TBL] [Abstract][Full Text] [Related]
17. Normalization matters: tracking the best strategy for sperm miRNA quantification. Corral-Vazquez C; Blanco J; Salas-Huetos A; Vidal F; Anton E Mol Hum Reprod; 2017 Jan; 23(1):45-53. PubMed ID: 27932553 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263 [TBL] [Abstract][Full Text] [Related]
19. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses. Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512 [TBL] [Abstract][Full Text] [Related]
20. Development of an miRNA-Array-Based Diagnostic Signature for Periodontitis. Jin SH; Zhou JG; Guan XY; Bai GH; Liu JG; Chen LW Front Genet; 2020; 11():577585. PubMed ID: 33391341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]